CRH and pneumococcal infection: Interestingly, intranasal administration of antalarmin significantly reduced the protective effect of CRH, suggesting that endogenous ligation of CRH to its cognate receptor CRHR1 could be mediating responses during pneumococcal infection (Fig. 2B).